CVS Health surprised Wall Street with an unexpected change in corporate leadership last month when it named David Joyner its newest president and CEO. Joyner replaces Karen Lynch, who had served as CEO since February 2021 and stepped down in an agreement with the company’s board of directors.

Joyner brings 37 years of experience in healthcare and pharmacy benefit management to CVS. His long career, including roles such as executive vice president of sales and marketing

CVS Health Chief Executive Officer Karen Lynch has stepped down and will be replaced by David Joyner, who runs the company's pharmacy benefit firm, Caremark.

CVS Health CEO Karen Lynch has stepped down and is being replaced by David Joyner amid struggles with rising costs.

Longtime executive David Joyner, 60, took over on Thursday after CVS repeatedly missed earnings targets, setting off unrest among shareholders that spilled into public view in recent weeks

Women have long faced more challenges than men while making their way to the uppermost ranks of prominent companies. And it’s harder for them to hold on to that top spot. Consider that CVS the healthcare company,

That has been the existential question for CVS Health for six years, since its $70 billion acquisition of the massive insurer Aetna. The biggest pharmacy chain in the U.S. had already been moving beyond retail since its 2007 deal for pharmacy benefit manager Caremark.